Spermidine regulates RIPK1 to combat diabetes and vascular damage

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, offering potential therapeutic strategies for type 2 diabetes.